Giselle Hosgood Selected Research

Hydroxyethyl Starch Derivatives (Pentastarch)

5/2021	Prospective randomized controlled blinded clinical trial evaluating biomarkers of acute kidney injury following 6% hydroxyethyl starch 130/0.4 or Hartmann's solution in dogs.
9/2019	Hydroxyethyl starch 130/0.4 (6%) and succinylated gelatine (4%) interfere with refractometry in dogs with haemorrhagic shock.
3/2019	Evaluation of biomarkers of kidney injury following 4% succinylated gelatin and 6% hydroxyethyl starch 130/0.4 administration in a canine hemorrhagic shock model.
5/2017	Hydroxyethyl starch 130/0.4 compared with 0.9% NaCl administered to greyhounds with haemorrhagic shock.
7/2016	Platelet closure time in anesthetized Greyhounds with hemorrhagic shock treated with hydroxyethyl starch 130/0.4 or 0.9% sodium chloride infusions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giselle Hosgood Research Topics

Disease

5	Shock 09/2019 - 03/2015
4	Hemorrhagic Shock 01/2020 - 07/2016
4	Hemorrhage 03/2019 - 01/2006
3	Hypothermia 04/2006 - 12/2003
2	Acute Kidney Injury (Acute Renal Failure) 05/2021 - 03/2019
2	Hypotension (Low Blood Pressure) 05/2017 - 05/2013
2	Infections 02/2011 - 07/2004
2	Intestinal Volvulus (Volvulus) 07/2005 - 04/2005
1	Wounds and Injuries (Trauma) 10/2022
1	Splenic Diseases 01/2019
1	Hypertrophy 07/2015
1	Lymphoma (Lymphomas) 01/2015
1	Thymoma (Thymic Carcinoma) 01/2015
1	Pancreatitis 03/2014
1	Mucocele 05/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2011
1	Pyoderma 02/2011
1	Glaucoma 11/2007
1	Urologic Diseases (Urinary Tract Disease) 09/2006
1	Gastric Dilatation (Stomach Dilatation) 07/2005
1	Hyperlipidemias (Hyperlipidemia) 01/2005
1	Hypersensitivity (Allergy) 12/2003
1	Joint Diseases (Joint Disease) 12/2002

Drug/Important Bio-Agent (IBA)

5	Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link 05/2021 - 07/2016
5	HES 130-0.4IBA 05/2021 - 07/2016
4	Starch (Cornstarch)IBA 05/2021 - 07/2016
4	Isoflurane FDA LinkGeneric 05/2017 - 12/2003
3	Colloids (Colloid)IBA 01/2020 - 01/2018
3	Fentanyl (Sublimaze)FDA LinkGeneric 04/2006 - 12/2003
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2005 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 05/2021 - 03/2019
2	Crystalloid SolutionsIBA 03/2019 - 01/2018
2	succinylated gelatinIBA 03/2019 - 01/2018
2	Saline SolutionIBA 05/2017 - 07/2016
2	Sodium Chloride FDA LinkGeneric 05/2017 - 07/2016
1	Ringer's LactateIBA 05/2021
1	BiuretIBA 09/2019
1	Blood Proteins (Serum Proteins)IBA 09/2019
1	Fibrinogen (Factor I)FDA Link 01/2018
1	AcidsIBA 05/2017
1	CollagenIBA 07/2016
1	Adenosine Diphosphate (ADP)IBA 07/2016
1	Pain-FreeIBA 07/2015
1	alphaxalone (alfaxalone)IBA 03/2015
1	Oxygen (Dioxygen)IBA 03/2015
1	Asparaginase (Elspar)FDA Link 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015
1	Prednisolone (Predate)FDA LinkGeneric 01/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2015
1	Vincristine (Oncovin)FDA LinkGeneric 01/2015
1	Lipase (Acid Lipase)FDA Link 03/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2013
1	Methicillin (Metin)FDA Link 02/2011
1	Novobiocin (Streptonivicin)FDA Link 02/2011
1	Mupirocin (Bactroban)FDA LinkGeneric 02/2011
1	Retinaldehyde (Retinal)IBA 11/2007
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2006
1	salicylhydroxamic acid (SHAM)IBA 04/2006
1	Adenosine Triphosphate (ATP)IBA 07/2005
1	Fish OilsIBA 01/2005
1	Vitamin E FDA LinkGeneric 01/2005
1	CytokinesIBA 07/2004
1	Halothane (Fluothane)FDA Link 04/2004
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2003
1	Endothelin-1 (Endothelin 1)IBA 12/2002

Therapy/Procedure

4	Anesthesia 07/2016 - 12/2003
2	Cutaneous Administration 04/2004 - 12/2003
1	Combined Modality Therapy 10/2022
1	Skin Transplantation (Skin Grafting) 10/2022
1	Splenectomy 01/2019
1	Hemodilution 01/2018
1	Resuscitation 07/2016
1	Drug Therapy (Chemotherapy) 01/2015
1	Neoadjuvant Therapy 01/2015
1	Cholecystectomy 05/2013
1	Ligation 01/2006
1	Surgical Instruments (Clip) 01/2006
1	Inhalation Anesthesia 04/2004